TERESA HARPER: Open Payments
NPI 1629547898 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,091 in 124 payments from 15 companies in 2025. Trend: 2023 $1,989 · 2024 $2,826 · 2025 $2,091
Food & beverage: $1,976Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $400 |
| Otsuka America Pharmaceutical, Inc. | 17 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $241 |
| Neurocrine BioSciences, Inc. | 14 | $236 |
| Alkermes, Inc. | 10 | $222 |
| Lundbeck LLC | 12 | $203 |
| Corium, LLC | 10 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Janssen Pharmaceuticals, Inc | 7 | $96 |
| Axsome Therapeutics, Inc. | 3 | $51 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, SPRAVATO, ARISTADA, Azstarys, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
